SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-065739
Filing Date
2015-02-26
Accepted
2015-02-26 16:25:35
Documents
8
Period of Report
2015-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d881714d8k.htm 8-K 28907
2 EX-4.1 d881714dex41.htm EX-4.1 551442
3 GRAPHIC g881714ex4_1pg067.jpg GRAPHIC 4005
4 GRAPHIC g881714ex4_1pg068.jpg GRAPHIC 5387
5 GRAPHIC g881714ex4_1pg069.jpg GRAPHIC 4781
6 GRAPHIC g881714ex4_1pg070.jpg GRAPHIC 5087
7 GRAPHIC g881714ex4_1pg072.jpg GRAPHIC 4502
8 GRAPHIC g881714ex4_1pg073.jpg GRAPHIC 6524
  Complete submission text file 0001193125-15-065739.txt   624238
Mailing Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421
Business Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 15652876
SIC: 2834 Pharmaceutical Preparations